Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Non-cash Items (2022 - 2025)

Historic Non-cash Items for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $307000.0.

  • Lucid Diagnostics' Non-cash Items rose 5583.76% to $307000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $307000.0, marking a year-over-year increase of 5583.76%. This contributed to the annual value of $199000.0 for FY2024, which is 7398.69% down from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' Non-cash Items is $307000.0, which was up 5583.76% from $446000.0 recorded in Q2 2025.
  • Lucid Diagnostics' Non-cash Items' 5-year high stood at $2.0 million during Q1 2025, with a 5-year trough of $499.0 in Q3 2022.
  • In the last 4 years, Lucid Diagnostics' Non-cash Items had a median value of $307000.0 in 2025 and averaged $439628.8.
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 6943907.82% in 2023, then tumbled by 7398.69% in 2024.
  • Lucid Diagnostics' Non-cash Items (Quarter) stood at $428000.0 in 2022, then surged by 78.74% to $765000.0 in 2023, then plummeted by 73.99% to $199000.0 in 2024, then surged by 54.27% to $307000.0 in 2025.
  • Its Non-cash Items was $307000.0 in Q3 2025, compared to $446000.0 in Q2 2025 and $2.0 million in Q1 2025.